Coalition of Wisconsin Aging Groups
Registered Principal Details
Business Or Interest:
Protect and preserve the legal rights and earned benefits of Wisconsin's 1.3 million elderly and people with disabilities. Funds are derived from annual volunteer-membership fees, donations, event sponsorships, public and private sector grants, foundations, educational and community outreach programs and estate planning.
Lobbying Interests:
Budget Issues, Administrative Rulings, Public Hearings, Legislative Bills, Legislative Meetings & Hearings, topics that would impact the rights and earned benefits of Wisconsin's 1.3 million elderly and people with disabilities and intergenerational issues, that impact the quality of life and health for all aging generations.
Protect and preserve the legal rights and earned benefits of Wisconsin's 1.3 million elderly and people with disabilities. Funds are derived from annual volunteer-membership fees, donations, event sponsorships, public and private sector grants, foundations, educational and community outreach programs and estate planning.
Lobbying Interests:
Budget Issues, Administrative Rulings, Public Hearings, Legislative Bills, Legislative Meetings & Hearings, topics that would impact the rights and earned benefits of Wisconsin's 1.3 million elderly and people with disabilities and intergenerational issues, that impact the quality of life and health for all aging generations.
Contact
RMG
Robert M Gundermann
30 West Mifflin Street, #406
Madison, WI 53703
(608) 215-8987
Gundermann@cwag.org
http://www.cwag.org
30 West Mifflin Street, #406
Madison, WI 53703
(608) 215-8987
Gundermann@cwag.org
http://www.cwag.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 54
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
Bill Text and History
6/4/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
Bill Text and History
For
Notification Date6/4/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 128
Relating to: requiring first responders to be trained to administer epinephrine delivery systems. (FE)
Bill Text and History
4/17/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: requiring first responders to be trained to administer epinephrine delivery systems. (FE)
Bill Text and History
For
Notification Date4/17/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 173
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
4/10/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date4/10/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 257
Relating to: advanced practice registered nurses, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE)
Bill Text and History
2025 Wisconsin Act 17
6/3/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: advanced practice registered nurses, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE)
Bill Text and History
2025 Wisconsin Act 17
For
Notification Date6/3/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 83
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
Bill Text and History
6/4/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)
Bill Text and History
For
Notification Date6/4/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 152
Relating to: financial eligibility for the Alzheimer’s family and caregiver support program. (FE)
Bill Text and History
2025 Wisconsin Act 21
3/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: financial eligibility for the Alzheimer’s family and caregiver support program. (FE)
Bill Text and History
2025 Wisconsin Act 21
For
Notification Date3/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 156
Relating to: requiring first responders to be trained to administer epinephrine delivery systems. (FE)
Bill Text and History
3/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: requiring first responders to be trained to administer epinephrine delivery systems. (FE)
Bill Text and History
For
Notification Date3/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 203
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
4/17/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
https://www.wi4patients.com/
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date4/17/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
https://www.wi4patients.com/
Senate Bill 258
Relating to: advanced practice registered nurses, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE)
Bill Text and History
6/3/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: advanced practice registered nurses, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE)
Bill Text and History
For
Notification Date6/3/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Copay Accumulators
Copay Accumulators
Action Intended To Affect
Legislative matter
Notification Date
3/14/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative matter
Notification Date
3/14/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Antipsychotic medications
Antipsychotic medications
Action Intended To Affect
Legislative matter
Notification Date
2/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative matter
Notification Date
2/27/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
| 2025 January - June |
Total | |
|---|---|---|
| Total Lobbying Expenditures | 2025 January - June $1,595.00 |
Total $1,595.00 |
| Total Hours Communicating | 2025 January - June 13.75 |
Total 13.75 |
| Total Hours Other | 2025 January - June 20.00 |
Total 20.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 30% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 30% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2025 January - June |
2025 July - December |
2026 January - June |
2026 July - December |
Total |
|---|---|---|---|---|
| 2025 January - June 50% |
2025 July - December |
2026 January - June |
2026 July - December |
Total 50% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication